Position in KROS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$850,102
-$4,461,638 QoQ
Shares Held
77,002
-70.5% QoQ
Ownership
0.388%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $848,581,551 across 184 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
622,603 | $34,205,808 |
All Filings in KROS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $850,102 | 77,002 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,311,740 | 260,891 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $677,080 | 42,799 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $150,271 | 14,747 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $337,212 | 5,807 | Shares | Defined | 2024-11-12 | |
| 2023-12-31 | $521,730 | 13,122 | Shares | Defined | 2024-02-09 | |
| 2022-12-31 | $1,019,080 | 21,222 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||